|
"hsu chih hung"的相关文件
显示项目 86-135 / 175 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2012 |
Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chiun; Lee, Kuan-Der; Hsiao, Chi-Huang; Lu, Yen-Shen; Huang, Chien-Chung; Shen, Yin-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 盧彥伸; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立臺灣大學 |
2012 |
Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy
|
Shao, Yu-Yun; Huang, Chien-Chung; Lin, Shiou-Der; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer
|
Lu, Li-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Hsu, Chun; Cheng, Wen-Fang; Lin, Yu-Lin; Cheng, Ann-Lii; Yeh, Kun-Huei; 鄭文芳; 邵幼雲; 林育麟; 鄭安理; 徐志宏; 許駿; 葉坤輝; 呂理駿 |
| 國立臺灣大學 |
2012 |
Dissimilar Immunohistochemical Expression of ERK and AKT between Paired Biopsy and Hepatectomy Tissues of Hepatocellular Carcinoma
|
Shao, Yu-Yun; Chen, Chi-Long; Ho, Ming-Chih; Huang, Chien-Chung; Tu, Hui-Ching; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 何明志 |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study
|
Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Breast Cancer Cells Induce Stromal Fibroblasts to Secrete ADAMTS1 for Cancer Invasion through an Epigenetic Change
|
Tyan, Shiaw-Wei; Hsu, Chih-Hung; Peng, Kai-Lin; Chen, Chun-Chin; Kuo, Wen-Hung; Lee, Eva Y. -H. P.; Shew, Jin-Yuh; Chang, King-Jen; Juan, Li-Jung; Lee, Wen-Hwa; 郭文宏; 張金堅 |
| 國立臺灣大學 |
2012 |
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Tzen, Kai-Yuan; Cheng, Jason C.; Lee, Jang-Ming; Wang, Hsiu-Po; Huang, Pei-Ming; Hsu, Feng-Ming; Chen, Wei-Wu; Huang, Ta-Chen; Cheng, Ann-Lii; 林家齊; 曾凱元; 鄭安理; 成佳憲; 黃大成; 徐志宏; 李章銘; 王秀伯; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
Transforming growth factor-beta mediated epithelial to mesenchymal transition contributes to in vivo resistance to sorafenib in hepatocellular carcinoma
|
Lin, Shiou-Der; Lin, Tzu-Hsuan; Feng, Wen-Chi; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 |
| 國立成功大學 |
2011-12 |
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo, Sung-Hsin; Cheng, Ann-Lii; Lin, Chung-Wu; Hsu, Chih-Hung; Wu, Ming-Shiang; Yeh, Kun-Huei; Tzeng, Yi-Shin; Chen, Li-Tzong |
| 東海大學 |
2011 |
青年族群的綠色消費概念之研究 －以東海大學學生為例
|
徐誌宏; Hsu, Chih-Hung |
| 國立虎尾科技大學 |
2011 |
Applying data mining and grey QFD to mine the dynamic trends for computer life cycle-oriented green supply
|
Hsu, Chih-Hung;Chang, An-Yuan;Kuo, Hui-Ming |
| 國立臺灣大學 |
2010 |
Combinations of Mtorc1 Inhibitor Rad001 with Gemcitabine and Paclitaxel for Treating Non-Hodgkin Lymphoma
|
江俊德; 葉培彥; 高明; 郭頌鑫; 徐志宏; 盧彥伸; 鄭安理; CHIANG, CHUN-TE; YEH, PEI-YEN; GAO, MING; KUO, SUNG-HSIN; HSU, CHIH-HUNG; LU, YEN-SHEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients with Advanced Hepatocellular Carcinoma
|
邵幼雲; 林宗哲; 許駿; 沈盈君; 徐志宏; 鄭安理; SHAO, YU-YUN; LIN, ZONG-ZHE; HSU, CHIUN; SHEN, YING-CHUN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Efficacy and Tolerability of Bevacizumab Plus Capecitabine as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
|
徐志宏; 許駿; 陳培哲; 林宗哲; 趙祖怡; 鄭安理; HSU, CHIH-HUNG; HSU, CHIUN; CHEN, PEI-JER; LIN, ZONG-ZHE; CHAO, TSU-YI; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (Dce-Mri) to Predict Treatment Outcomes for Advanced Hepatocellular Carcinoma (Hcc) Patients Who Received Sorafenib Plus Tegafur/Uracil Therapy
|
沈盈君; 許昭禹; 游治維; 許駿; 徐志宏; 鄭安理; 施庭芳; SHEN, YING-CHUN; HSU, CHAO-YU; YU, CHIH-WEI; HSU, CHIUN; HSU, CHIH-HUNG; CHENG, ANN-LII; SHIH, TIFFANY TING-FANG |
| 國立臺灣大學 |
2010 |
Modulation of Human Ump/Cmp Kinase Affects Activation and Cellular Sensitivity of Deoxycytidine Analogs
|
劉界元; 徐志宏; 張瑋玲; 黃煜珺; 鄭永齊; LIOU, JIEH-YUAN; HSU, CHIH-HUNG; CHANG, WEI-LING; HUANG, YU-CHUN; CHENG, YUNG-CHI |
| 國立臺灣大學 |
2010 |
Phase Ii Study of Combining Sorafenib with Metronomic Tegafur/Uracil for Advanced Hepatocellular Carcinoma
|
徐志宏; 沈盈君; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 許駿; 鄭安理; HSU, CHIH-HUNG; SHEN, YING-CHUN; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009-12 |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin, Chia-Chi; Hsu, Chih-Hung; Cheng, Jason C.; Huang, Chao-Yuan; Tsai, Yu-Chieh; Hsu, Feng-Ming; Huang, Kuo-How; Cheng, Ann-Lii; Pu, Yeong-Shiau |
| 國立臺灣大學 |
2009 |
不同方法之震譜相符強地動歷時對結構地震需求之變異性探討
|
許志鴻; Hsu, Chih-Hung |
| 國立臺灣大學 |
2009 |
The Aurora Kinase Inhibitor Ve-465 Has Anticancer Effects in Pre-Clinical Studies of Human Hepatocellular Carcinoma
|
許輝吉; 徐志宏; 葉培彥; 黃繼瑩; 郭頌鑫; 許駿; 胡賦強; 鄭永銘; 鄭安理; HSU, HEY-CHI; HSU, CHIH-HUNG; YEH, PEI-YEN; HUANG, CHI-YING; KUO, SUNG-HSIN; HSU, CHIUN; HU, FU-CHANG; JENG, YUNG-MING; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Bevacizumab (B) and Erlotinib (E) in Combination for Asian Patients (Pts) with Advanced/Metastatic Hepatocellular Carcinoma ( Hcc): An Interim Safety Report
|
徐志宏; 邱宗傑; 許駿; 鄭安理; HSU, CHIH-HUNG; CHIOU, TZEON-JYE; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Sorafenib in Combination with Tegafur/Uracil (Uft) for Asian Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 許駿; 徐志宏; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; HSU, CHIUN; HSU, CHIH-HUNG; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Trial of Thalidomide Plus Tegafur/Uracil for Patients with Advanced/Metastatic Hepatocellular Carcinoma (Hcc): Final Report
|
徐志宏; 林宗哲; 沈盈君; 許駿; 鄭安理; HSU, CHIH-HUNG; LIN, ZONG-ZHE; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complications in Esophageal Cancer Patients Receiving Intensity- Modulated Radiation Therapy and Concurrent Chemotherapy Followed by Thoracic Esophagectomy
|
許峰銘; 李元麒; 李章銘; 徐志宏; 林家齊; 蔡育傑; 吳簡坤; 成佳憲; HSU, FENG-MING; LEE, YUNG-CHIE; LEE, JANG-MING; HSU, CHIH-HUNG; LIN, CHIA-CHI; TSAI, YU-CHIEH; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2009 |
Disseminated Peritoneal Leiomyomatosis Responds to Systemic Chemotherapy
|
林育靖; 魏凌鴻; 孫家棟; 鄭安理; 徐志宏; LIN, YU-CHIN; WEI, LIN-HUNG; SHUN, CHIA-TUNG; CHENG, ANN-LII; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2009 |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
林家齊; 徐志宏; 成佳憲; 黃昭淵; 蔡育傑; 許峰銘; 黃國皓; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; CHENG, JASON CHIA- HSIEN; HUANG, CHAO-YUAN; TSAI, YU-CHIEH; HSU, FENG -MING; HUANG, KUO-HOW; CHENG, ANN-LII; PU, YEONG- SHIAU |
| 國立臺灣大學 |
2009 |
Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy
|
林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer
|
葉坤輝; 徐志宏; 許駿; 林璟宏; 沈盈君; 邱宗傑; 趙毅; 鄭安理; YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII |
| 國立臺灣大學 |
2008-07 |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu, Feng-Ming; Lin, Chia-Chi; Lee, Jang-Ming; Chang, Yih-Leong; Hsu, Chih-Hung; Tsai, Yu-Chieh; Lee, Yung-Chie; Cheng, Jason Chia-Hsien |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 國立臺灣大學 |
2008-04 |
Systemic therapy for metastatic urothelial carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Pu, Yeong-Shiau; Vogelzang, Nicholas J. |
| 國立臺灣大學 |
2008 |
Acute Encephalopathy Following Arsenic Trioxide for Metastatic Urothelial Carcinoma
|
林家齊; 蒲永孝; 徐志宏; 耿孝宜; 鄭安理; 楊志新; LIN, CHIA-CHI; PU, YEONG-SHIAU; HSU, CHIH-HUNG; KENG, HSIAO-YI; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complication in Esophageal Cancer Patients Receiving Intensity Modulated Radiation Therapy Followed by Esophagectomy
|
許峰銘; 吳簡坤; 李元麒; 李章銘; 林家齊; 徐志宏; 蔡育傑; 成佳憲; HSU, FENG-MING; WU, JIAN-KUEN; LEE, YUNG-CHIE; LEE, JANG-MING; LIN, CHIA-CHI; HSU, CHIH-HUNG; TSAI, YU-CHIEH; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Improved Local Control by Surgery and Paclitaxel-Based Chemoradiation for Esophageal Squamous Cell Carcinoma: Results of a Retrospective Non- Randomized Study
|
許峰銘; 林家齊; 李章銘; 張逸良; 徐志宏; 蔡育傑; 李元麒; 成佳憲; HSU, FENG-MING; LIN, CHIA-CHI; LEE, JANG-MING; CHANG, YIH-LEONG; HSU, CHIH-HUNG; TSAI, YU-CHIEH; LEE, YUNG-CHIE; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Osu-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species- Related Autophagy in Hepatocellular Carcinoma
|
高明; 葉培彥; 盧彥伸; 徐志宏; 陳昆鋒; 陳慶士; 郭明良; 鄭安理; GAO, MING; YEH, PEI-YEN; LU, YEN-SHEN; HSU, CHIH-HUNG; CHEN, KUEN-FENG; CHEN, CHING-SHIH; KUO, MIN-LIANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Systemic Therapy for Metastatic Urothelial Carcinoma
|
林家齊; 徐志宏; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2008 |
Weekly 24-Hour Infusional 5-Fluorouracil as Initial Treatment for Advanced Gastric Cancer with Acute Disseminated Intravascular Coagulation
|
黃大成; 葉坤輝; 鄭安理; 徐志宏; HUANG, DA-CHEN; YEH, KUN-HUEI; CHENG, ANN-LII; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2008 |
Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2
|
陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立成功大學 |
2007-07 |
A Lagrangian modeling approach with the direct simulation Monte-Carlo method for inter-particle collisions in turbulent flow
|
Hsu, Chih-Hung; Chang, Keh-Chin |
| 國立高雄第一科技大學 |
2007-06-07 |
文化差異對任務執行力影響程度之研究
|
許智紘; Hsu Chih-Hung |
| 國立臺灣大學 |
2007-05 |
Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial
|
Lin, Chia-Chi; Hsu, Chih-Hung; Hour, Tzyh-Chyuan; Cheng, Ann-Lii; Huang, Chao-Yuan; Huang, Kuo-How; Chen, Jun; Pu, Yeong-Shiau |
| 國立臺灣大學 |
2007-03 |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Tsai, Yu-Chieh; Huang, Kuo-How; Cheng, Ann-Lii; Pu, Yeong-Shiau |
| 國立臺灣大學 |
2007-01 |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (TP-HDFL) for Metastatic Urothelial Carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Pu, Nicholas J. Vogelzang Yeong-Shiau |
| 國立臺灣大學 |
2007 |
Esophageal Adenocarcinoma Arising from Barrett's Epithelium in Taiwan
|
涂佳宏; 彭道雄; 張淳昭; 徐志宏; 李宜家; TU, CHIA-HUNG; PERNG, DAW-SHYONG; CHANG, CHUN-CHAO; HSU, CHIH-HUNG; LEE, YI-CHIA |
| 國立臺灣大學 |
2007 |
Concurrent Chemoradiotherapy with Twice Weekly Paclitaxel and Cisplatin Followed by Esophagectomy for Locally Advanced Esophageal Cancer
|
林家齊; 徐志宏; 王秀伯; 李章銘; 葉坤輝; 楊志新; 林肇堂; 鄭安理; 李元麒; LIN, CHIA-CHI; HSU, CHIH-HUNG; WANG, HSIU-PO; LE,E JANG-MING; YEH, KUN-HUEI; YANG, CHIH-HSIN; LIN, JAW-TOWN; CHENG, ANN-LII; LEE, YUNG-CHIE |
显示项目 86-135 / 175 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目
|
